Posted in

MBI Events

MBI Research Evening – Pre-SfN Data Blitz

On Wednesday, Nov. 8, dozens of researchers from eight departments participated in the McKnight Brain Institute Research Evening — Pre-Society for Neuroscience (SfN) Data Blitz event.

Explore More: Innovation in Immunotherapy

Duane Mitchell, M.D., Ph.D., co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer Center, presented a conversation about the use of immunotherapy to treat brain cancers on Monday, Feb. 13 at 6 p.m.

Brain Awareness Week March 13-16

Brain Awareness Week 2017 kicks off March 13 with the fifth annual William G. Luttge Lectureship in Neuroscience, sponsored by the McKnight Brain Research Foundation. This year’s speaker is James L. McGaugh, Ph.D., research professor of neurobiology and behavior at the University of California, Irvine. McGaugh, who has published more…

Powerful new 3T MRI comes to the MBI

The Siemens 3T MRI/S is a state-of-the-art $3 million scanner that has the strongest gradients available for human imaging, advanced motion correction capabilities and increased scanning flexibility. The new 3T will support a rapidly increasing number of federally funded UF investigators who are studying Parkinson’s disease, muscular dystrophy, aging…

Ken Marx named new MBI director of operations

The MBI welcomes Ken Marx as its new director of operations. Marx, who previously served as chief administrator for UF’s department of emergency medicine for 15 years, succeeds Kelly Sharp, who is now executive director of administration and finance at the UF College of Pharmacy. Marx started his career as…

New console for the 11.1 tesla

In August at the MagLab, engineers installed a new “control center” for one of our magnet systems that will result in faster experimental set-up times, more sensitive readings and detailed information for functional MRI experiments — all contributing to a wide range of neuroscience applications, such as pharmacological MRI. The beneficiary…

Biomarker breakthrough could improve Parkinson’s treatment

A new, non-invasive way to track the progression of Parkinson’s disease could help evaluate experimental treatments to slow or stop the disease’s progression. University of Florida researchers used functional magnetic resonance imaging to reveal areas where Parkinson’s disease and related conditions cause progressive decline in brain activity. The study, funded…